June 8, 2022 | By John Raslavsky | Clinical Research, Hepatitis B | Blog, Clinical trials, liver health, Liver research
Like many other liver diseases, hepatitis B is a “silent epidemic” because most people do not have symptoms for most of the disease progression. It is one of the most common serious liver infections globally and in the state of …
May 31, 2022 | By John Raslavsky | Clinical Research, Jaundice, NASH | bilirubin and liver function, Blog, Clinical trials, Liver research, NASH Complications
Jaundice is a yellowing of the eye sclera (the white part) and skin because there’s too much bilirubin in the blood. There are many causes of jaundice. However, for people living with liver disease, jaundice is a common nonalcoholic steatohepatitis …
May 11, 2022 | By John Raslavsky | Clinical Research, Hepatitis C | Blog, Clinical trials, Liver research, NASH
Hepatitis C is a liver infection from the hepatitis C virus (HCV). For some people, HCV causes short-term illness. However, for more than half, it becomes a long-term, chronic infection that can result in severe and life-threatening health problems. Liver …
April 26, 2022 | By John Raslavsky | Clinical Research, Effects of Alcohol on the Liver, Fibroscan | AFLD, Blog, Clinical trials, Fatty Liver Disease, liver health
Alcohol is one of the most widely used substances among America’s adult and teen populations, posing substantial health and safety risks. Even though most know the adverse effects of alcohol, many tend to do so without fully recognizing the health …
April 7, 2022 | By John Raslavsky | Clinical Trials, Liver Disease, Minority Participation in Liver Research | Blog, Diversity in research, Fatty Liver Disease, NAFLD, NASH, National Minority Health Month
April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause …
March 30, 2022 | By John Raslavsky | Clinical Research, Hepatitis | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research, NAFLD, NASH
Liver health is essential to the function of the human body. It performs over 500 functions to keep the body healthy. A few examples are flushing out toxins, processing food, and maintaining healthy blood sugar levels. Hepatitis is one of …
March 7, 2022 | By John Raslavsky | Fibroscan, Liver Disease | Blog, NAFLD, NASH, Women's History Month
March is Women’s History Month, and it commemorates women’s contributions to history, culture, and society. The 2022 theme is “Women Providing Healing, Promoting Hope.” It is a tribute to the countless ways women of all cultures provide healing and hope …
February 28, 2022 | By John Raslavsky | Clinical Trials, Liver Health | Blog, liver disease research, NAFLD, NASH
There’s a lot of love to celebrate during the month of February. However, some of the things we love are bad for our overall health. One of these areas is our obsession with the “western diet,” which is high in …
February 14, 2022 | By John Raslavsky | Clinical Research, Liver Health | American heart month, Blog, Clinical trials, heart-liver connection, Liver research
When we think of hearts, we think of Valentine’s Day and the exchange of cards and unique trinkets shared with our family and friends. February is also American Heart Month which creates awareness about heart disease, the number one cause …
January 31, 2022 | By John Raslavsky | Clinical Trials, Liver | Blog, liver health, Liver research, NAFLD, NASH
You can start this year on the right foot by taking proactive steps for your health and well-being. If you’ve been diagnosed with liver disease, keeping your liver healthy is essential. It’s a new year, and it’s time to set …